NDC 50402-100

IDkit HP ONE

Citric Acid Anhydrous And 13c Urea

IDkit HP ONE is a Oral Kit in the Human Prescription Drug category. It is labeled and distributed by Exalenz Bioscience Ltd.. The primary component is .

Product ID50402-100_243d0321-266d-4f8c-a8f4-2c311eb839d1
NDC50402-100
Product TypeHuman Prescription Drug
Proprietary NameIDkit HP ONE
Generic NameCitric Acid Anhydrous And 13c Urea
Dosage FormKit
Route of AdministrationORAL
Marketing Start Date2009-12-28
Marketing CategoryNDA / NDA
Application NumberNDA021314
Labeler NameExalenz Bioscience Ltd.
Active Ingredient Strength0
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 50402-100-13

25 BAG in 1 BOX (50402-100-13) > 1 KIT in 1 BAG
Marketing Start Date2013-05-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50402-100-14 [50402010014]

IDkit HP ONE KIT
Marketing CategoryNDA
Application NumberNDA021314
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2017-01-01

NDC 50402-100-11 [50402010011]

IDkit HP ONE KIT
Marketing CategoryNDA
Application NumberNDA021314
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-12-28
Marketing End Date2020-01-02
Inactivation Date2019-10-29
Reactivation Date2020-01-02

NDC 50402-100-22 [50402010022]

IDkit HP ONE KIT
Marketing CategoryNDA
Application NumberNDA021314
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-12-28
Marketing End Date2020-01-02
Inactivation Date2019-10-29
Reactivation Date2020-01-02

NDC 50402-100-13 [50402010013]

IDkit HP ONE KIT
Marketing CategoryNDA
Application NumberNDA021314
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-05-01

NDC 50402-100-02 [50402010002]

IDkit HP ONE KIT
Marketing CategoryNDA
Application NumberNDA021314
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-12-28
Marketing End Date2020-01-02

NDC 50402-100-01 [50402010001]

IDkit HP ONE KIT
Marketing CategoryNDA
Application NumberNDA021314
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-12-28
Marketing End Date2020-01-02

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.